THE NHS EXPENDITURE MANAGING SEVERE HYPOGLYCEMIA EPISODES IN TYPE 2 DIABETIC PATIENTS IN PORTUGAL

Author(s)

Laires PA1, Conceição J1, Araújo F2, Dores J3, Silva C4, Radican L5, Nogueira AM1
1Merck Sharp & Dohme, Oeiras, Portugal, 2Hospital Beatriz Angelo, Loures, Portugal, 3Hospital Santo António, Porto, Portugal, 4Eurotrials, Scientific Consultants, Lisbon, Portugal, 5Merck Sharp & Dohme Corp., Rahway, NJ, USA

OBJECTIVES: Hypoglycemia is an acute complication of diabetes that increases the morbidity, mortality and disease costs. We aimed to estimate the annual NHS expenditure managing severe hypoglycemia episodes in type 2 diabetic patients in Portugal. METHODS: HIPOS-ER (Hypoglycemia in Portugal Observational Study – Emergency Room) study was an observational, cross-sectional, multicenter, hospital-based study conducted in seven centers of Portugal mainland within a period of 12 months (January 2013 - January 2014). Patient level data were used to quantify healthcare resource consumption related to emergency transportation, emergency department care and hospitalization. Unit costs for 2014 were extracted from official sources and reported in euros. RESULTS: A total of 425,706 admissions at the emergency room were registered in the participating hospitals within the shifts covered by HIPOS-ER study. Of these, 0.074% had diabetes type 2 and were admitted due to an episode of hypoglycemia meaning that theoretically 2.317 emergencies occur yearly in Portugal due to severe hypoglycemia in Type 2 diabetic patients (out of an universe of 3.131.126 annual general emergencies in Portugal). Considering the HIPOS-ER estimated mean cost for managing this type of hypoglycemia (i.e. €1,479), we expect that around 3.4 millions of euros per year are spent in treating this diabetes related complication at emergency rooms of NHS Portuguese hospitals. CONCLUSIONS: Our estimation highlights the potential overall economic burden of severe hypoglycemias in Portugal, meaning that this diabetes-related event must be taken in consideration by different healthcare stakeholders not only from strict clinical point of view, but also from and economic one.  We conclude that severe hypoglycemic events represent a substantial cost for society and in particular for the hospitals of the National Health Service.

Conference/Value in Health Info

2015-11, ISPOR Europe 2015, Milan, Italy

Value in Health, Vol. 18, No. 7 (November 2015)

Code

PDB25

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis, Cost/Cost of Illness/Resource Use Studies

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×